Citadel Advisors’s Select Medical SEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-7,700
| Closed | -$129K | – | 14785 |
|
|
2025
Q1 | $129K | Sell |
7,700
-2,800
| -27% | -$51.5K | ﹤0.01% | 11107 |
|
|
2024
Q4 | $198K | Buy |
10,500
+4,004
| +62% | +$77.2K | ﹤0.01% | 10480 |
|
|
2024
Q3 | $122K | Buy |
6,496
+2,598
| +67% | +$49.8K | ﹤0.01% | 10851 |
|
|
2024
Q2 | $73.6K | Sell |
3,898
-4,640
| -54% | -$79.1K | ﹤0.01% | 11312 |
|
|
2024
Q1 | $139K | Buy |
8,538
+1,671
| +24% | +$24.5K | ﹤0.01% | 10882 |
|
|
2023
Q4 | $87K | Sell |
6,867
-12,250
| -64% | -$155K | ﹤0.01% | 11109 |
|
|
2023
Q3 | $260K | Sell |
19,117
-1,113
| -6% | -$17.2K | ﹤0.01% | 9419 |
|
|
2023
Q2 | $347K | Buy |
20,230
+15,404
| +319% | +$239K | ﹤0.01% | 8715 |
|
|
2023
Q1 | $67.2K | Sell |
4,826
-9,836
| -67% | -$145K | ﹤0.01% | 11792 |
|
|
2022
Q4 | $196K | Buy |
+14,662
| New | +$190K | ﹤0.01% | 10171 |
|
|
2022
Q3 | – | Sell |
-16,147
| Closed | -$205K | – | 13505 |
|
|
2022
Q2 | $205K | Sell |
16,147
-6,125
| -28% | -$78.6K | ﹤0.01% | 10648 |
|
|
2022
Q1 | $288K | Sell |
22,272
-2,784
| -11% | -$36.8K | ﹤0.01% | 10691 |
|
|
2021
Q4 | $397K | Buy |
25,056
+2,970
| +13% | +$50.7K | ﹤0.01% | 10248 |
|
|
2021
Q3 | $430K | Sell |
22,086
-62,362
| -74% | -$1.24M | ﹤0.01% | 10247 |
|
|
2021
Q2 | $1.92M | Buy |
84,448
+1,485
| +2% | +$30.8K | ﹤0.01% | 6720 |
|
|
2021
Q1 | $1.52M | Buy |
82,963
+65,702
| +381% | +$1.08M | ﹤0.01% | 7057 |
|
|
2020
Q4 | $257K | Sell |
17,261
-6,496
| -27% | -$84.8K | ﹤0.01% | 9350 |
|
|
2020
Q3 | $266K | Sell |
23,757
-8,352
| -26% | -$82.2K | ﹤0.01% | 8346 |
|
|
2020
Q2 | $255K | Sell |
32,109
-18,931
| -37% | -$157K | ﹤0.01% | 8173 |
|
|
2020
Q1 | $413K | Buy |
51,040
+5,382
| +12% | +$64K | ﹤0.01% | 6773 |
|
|
2019
Q4 | $574K | Buy |
+45,658
| New | +$492K | ﹤0.01% | 6603 |
|
|
2019
Q3 | – | Sell |
-29,882
| Closed | -$256K | – | 9694 |
|
|
2019
Q2 | $256K | Sell |
29,882
-1,484
| -5% | -$11.7K | ﹤0.01% | 7833 |
|
|
2019
Q1 | $238K | Sell |
31,366
-61,434
| -66% | -$494K | ﹤0.01% | 7952 |
|
|
2018
Q4 | $768K | Buy |
92,800
+72,755
| +363% | +$696K | ﹤0.01% | 5719 |
|
|
2018
Q3 | $199K | Sell |
20,045
-8,723
| -30% | -$90.3K | ﹤0.01% | 8221 |
|
|
2018
Q2 | $281K | Sell |
28,768
-59,206
| -67% | -$581K | ﹤0.01% | 7319 |
|
|
2018
Q1 | $818K | Buy |
87,974
+11,692
| +15% | +$111K | ﹤0.01% | 5101 |
|
|
2017
Q4 | $725K | Buy |
+76,282
| New | +$729K | ﹤0.01% | 5108 |
|
|
2016
Q1 | – | Sell |
-2,970
| Closed | -$19K | – | 7826 |
|
|
2015
Q4 | $19K | Sell |
2,970
-17,632
| -86% | -$110K | ﹤0.01% | 7968 |
|
|
2015
Q3 | $120K | Buy |
20,602
+5,568
| +37% | +$41.3K | ﹤0.01% | 6779 |
|
|
2015
Q2 | $131K | Sell |
15,034
-25,612
| -63% | -$215K | ﹤0.01% | 6806 |
|
|
2015
Q1 | $325K | Buy |
40,646
+7,609
| +23% | +$56.9K | ﹤0.01% | 5538 |
|
|
2014
Q4 | $256K | Buy |
33,037
+21,715
| +192% | +$158K | ﹤0.01% | 5660 |
|
|
2014
Q3 | $73K | Buy |
11,322
+9,837
| +662% | +$76K | ﹤0.01% | 6649 |
|
|
2014
Q2 | $12K | Buy |
+1,485
| New | +$11.5K | ﹤0.01% | 7524 |
|
Other funds holding SEM
VPM
VCM
GCL
Citadel Advisors's SEM Position: Q1 2026 in Review
Citadel Advisors reduced its Select Medical (SEM) stake by 75% in Q1 2026, selling an estimated $2.6M and leaving 56,153 shares worth $915K. The position accounts for ﹤0.01% of the portfolio, ranked #7861.
Citadel Advisors first reported a position in SEM in Q2 2013 and has held it in 46 quarters since. The position peaked at $10.1M in Q1 2023. 277 funds tracked by Wall St. Rank hold SEM as of Q1 2026.
- Citadel Advisors held 56,153 shares of Select Medical worth $915K as of Q1 2026.
- Citadel Advisors sold 166,032 Select Medical shares in Q1 2026, an estimated $2.6M.
- Select Medical made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #7861 holding.
- Citadel Advisors first reported a position in Select Medical in Q2 2013 and has held it in 46 quarters since.
- Citadel Advisors's Select Medical position peaked at $10.1M in Q1 2023.
- 277 funds tracked by Wall St. Rank held Select Medical as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.